EMERGENT BIOSOLUTIONS INC. Increase (Decrease) in Accounts Receivable
EMERGENT BIOSOLUTIONS INC. (EBS) reported Increase (Decrease) in Accounts Receivable of $107.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $68.80M.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $38.90M, a 46.93% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$51.90M, a 167.32% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $71.60M.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in accounts receivable for fiscal 2025 was -$25.50M, a 204.51% decline from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in accounts receivable for fiscal 2024 was $24.40M, a 12.96% increase from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in accounts receivable for fiscal 2023 was $21.60M.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in accounts receivable for fiscal 2022 was -$118.10M, a 829.01% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $68.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $107.70M 10-Q · filed 2026-08-06 | $55.80M derived: sum of 3 quarters · filed 2026-08-06 | $127.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $38.90M 10-Q · filed 2026-05-01 | -$13.00M derived: sum of 2 quarters · filed 2026-05-01 | $58.60M derived: sum of 3 quarters · filed 2026-05-01 | -$59.90M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$51.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $19.70M derived: sum of 2 quarters · filed 2026-02-27 | -$98.80M derived: sum of 3 quarters · filed 2026-08-06 | -$25.50M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $71.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$46.90M derived: sum of 2 quarters · filed 2026-08-06 | $26.40M 10-Q · filed 2025-10-30 | $103.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$118.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$45.20M 10-Q · filed 2026-08-06 | $31.90M derived: sum of 3 quarters · filed 2026-08-06 | -$50.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $73.30M 10-Q · filed 2026-05-01 | $150.40M derived: sum of 2 quarters · filed 2026-05-01 | $68.10M derived: sum of 3 quarters · filed 2026-05-01 | $47.70M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $77.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$5.20M derived: sum of 2 quarters · filed 2026-02-27 | -$25.60M derived: sum of 3 quarters · filed 2026-02-27 | $24.40M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | -$82.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$102.70M derived: sum of 2 quarters · filed 2025-10-30 | -$52.70M 10-Q · filed 2025-10-30 | -$89.60M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | -$20.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $29.60M 10-Q · filed 2025-08-07 | -$7.30M derived: sum of 3 quarters · filed 2026-02-27 | -$78.60M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $50.00M 10-Q · filed 2025-05-08 | $13.10M derived: sum of 2 quarters · filed 2026-02-27 | -$58.20M derived: sum of 3 quarters · filed 2026-02-27 | $74.20M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | -$36.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$108.20M derived: sum of 2 quarters · filed 2026-02-27 | $24.20M derived: sum of 3 quarters · filed 2026-02-27 | $21.60M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | -$71.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $61.10M derived: sum of 2 quarters · filed 2024-11-07 | $58.50M 10-Q · filed 2024-11-07 | $22.90M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-06-30 | $132.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $129.80M 10-Q · filed 2024-08-07 | $130.60M 10-Q · filed 2023-08-09 | $94.20M derived: sum of 3 quarters · filed 2025-03-04 | $109.40M derived: sum of 4 quarters · filed 2025-03-04 | |||
| 2023-03-31 | -$2.60M 10-Q · filed 2024-05-02 | -$1.80M 10-Q · filed 2023-05-10 | -$38.20M derived: sum of 2 quarters · filed 2025-03-04 | -$23.00M derived: sum of 3 quarters · filed 2025-03-04 | -$27.00M derived: sum of 4 quarters · filed 2025-03-04 | |||
| 2022-12-31 | -$35.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$20.40M derived: sum of 2 quarters · filed 2025-03-04 | -$24.40M derived: sum of 3 quarters · filed 2025-03-04 | -$118.10M 10-K · filed 2025-03-04 | -$114.70M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $15.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11 | $11.20M derived: sum of 2 quarters · filed 2023-12-11 | -$82.50M 10-Q · filed 2023-12-11 | -$76.20M 10-Q · filed 2022-11-09 | -$181.00M derived: sum of 4 quarters · filed 2024-03-08 | |||
| 2022-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$97.70M 10-Q · filed 2023-08-09 | -$196.20M derived: sum of 3 quarters · filed 2024-03-08 | -$116.20M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | -$93.70M 10-Q · filed 2023-05-10 | -$192.20M derived: sum of 2 quarters · filed 2024-03-08 | -$112.20M derived: sum of 3 quarters · filed 2024-03-08 | -$35.40M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | -$98.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$18.50M derived: sum of 2 quarters · filed 2024-03-08 | $58.30M derived: sum of 3 quarters · filed 2024-03-08 | $16.20M 10-K · filed 2024-03-08 | $48.20M 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $80.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $156.80M derived: sum of 2 quarters · filed 2022-11-09 | $114.70M 10-Q · filed 2022-11-09 | $161.80M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-06-30 | $76.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $34.70M 10-Q · filed 2022-08-02 | $81.80M derived: sum of 3 quarters · filed 2023-12-11 | $19.30M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-03-31 | -$42.10M 10-Q · filed 2022-04-29 | $5.00M derived: sum of 2 quarters · filed 2023-12-11 | -$57.50M derived: sum of 3 quarters · filed 2023-12-11 | $38.60M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2020-12-31 | $47.10M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | -$15.40M derived: sum of 2 quarters · filed 2023-12-11 | $80.70M derived: sum of 3 quarters · filed 2023-12-11 | -$27.50M 10-K/A · filed 2023-12-11 | -$49.00M 10-K · filed 2021-02-19 | |||
| 2020-09-30 | -$62.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $33.60M derived: sum of 2 quarters · filed 2021-11-05 | -$74.60M 10-Q · filed 2021-11-05 | -$85.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $96.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$12.10M 10-Q · filed 2021-07-30 | -$22.50M derived: sum of 3 quarters · filed 2022-02-25 | $40.70M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | -$108.20M 10-Q · filed 2021-04-30 | -$118.60M derived: sum of 2 quarters · filed 2022-02-25 | -$55.40M derived: sum of 3 quarters · filed 2022-02-25 | $41.60M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | -$10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $52.80M derived: sum of 2 quarters · filed 2022-02-25 | $149.80M derived: sum of 3 quarters · filed 2022-02-25 | $8.20M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $63.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $160.20M derived: sum of 2 quarters · filed 2020-11-06 | $18.60M 10-Q · filed 2020-11-06 | $179.30M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $97.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$44.60M 10-Q · filed 2020-07-31 | $116.10M derived: sum of 3 quarters · filed 2021-02-19 | $3.40M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | -$141.60M 10-Q · filed 2020-05-01 | $19.10M derived: sum of 2 quarters · filed 2021-02-19 | -$93.60M derived: sum of 3 quarters · filed 2021-02-19 | -$25.60M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | $160.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $48.00M derived: sum of 2 quarters · filed 2021-02-19 | $116.00M derived: sum of 3 quarters · filed 2021-02-19 | $94.20M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | -$112.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$44.70M derived: sum of 2 quarters · filed 2019-11-07 | -$66.50M 10-Q · filed 2019-11-07 | -$66.45M 10-Q · filed 2018-11-02 | -$52.29M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $68.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $46.20M 10-Q · filed 2019-08-02 | $46.25M 10-Q · filed 2018-08-03 | $60.41M derived: sum of 3 quarters · filed 2020-02-25 | $87.16M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | -$21.80M 10-Q · filed 2019-05-08 | -$21.82M 10-Q · filed 2018-05-04 | -$7.59M derived: sum of 2 quarters · filed 2020-02-25 | $19.16M derived: sum of 3 quarters · filed 2020-02-25 | -$6.44M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $14.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $40.96M derived: sum of 2 quarters · filed 2020-02-25 | $15.36M derived: sum of 3 quarters · filed 2020-02-25 | $4.80M 10-K · filed 2020-02-25 | $4.81M 10-K · filed 2018-02-23 | |||
| 2017-09-30 | $26.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $1.15M derived: sum of 2 quarters · filed 2018-11-02 | -$9.41M 10-Q · filed 2018-11-02 | $58.02M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-06-30 | -$25.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$36.16M 10-Q · filed 2018-08-03 | $31.27M derived: sum of 3 quarters · filed 2019-02-22 | $40.17M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-03-31 | -$10.56M 10-Q · filed 2018-05-04 | $10.56M 10-Q · filed 2017-05-05 | $56.87M derived: sum of 2 quarters · filed 2019-02-22 | $65.77M derived: sum of 3 quarters · filed 2019-02-22 | -$39.37M derived: sum of 4 quarters · filed 2019-02-22 | |||
| 2016-12-31 | $67.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $76.33M derived: sum of 2 quarters · filed 2019-02-22 | -$28.81M derived: sum of 3 quarters · filed 2019-02-22 | $22.40M 10-K · filed 2019-02-22 | $22.45M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $8.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$96.24M derived: sum of 2 quarters · filed 2017-11-03 | -$45.03M 10-Q · filed 2017-11-03 | $45.03M 10-Q · filed 2016-11-09 | $17.57M derived: sum of 4 quarters · filed 2018-02-23 | |||
| 2016-06-30 | -$105.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$53.93M 10-Q · filed 2017-08-04 | $8.67M derived: sum of 3 quarters · filed 2018-02-23 | -$30.47M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-03-31 | $51.21M 10-Q · filed 2017-05-05 | -$51.21M 10-Q · filed 2016-05-06 | $113.81M derived: sum of 2 quarters · filed 2018-02-23 | $74.67M derived: sum of 3 quarters · filed 2018-02-23 | $110.33M derived: sum of 4 quarters · filed 2018-02-23 | |||
| 2015-12-31 | $62.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $23.47M derived: sum of 2 quarters · filed 2018-02-23 | $59.13M derived: sum of 3 quarters · filed 2018-02-23 | $64.35M 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | -$39.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$3.48M derived: sum of 2 quarters · filed 2016-11-09 | $1.75M 10-Q · filed 2016-11-09 | -$1.75M 10-Q · filed 2015-11-06 | $16.45M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | $35.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $40.88M 10-Q · filed 2016-08-05 | $55.59M derived: sum of 3 quarters · filed 2017-02-28 | $21.75M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $5.22M 10-Q · filed 2016-05-06 | $19.93M derived: sum of 2 quarters · filed 2017-02-28 | -$13.91M derived: sum of 3 quarters · filed 2017-02-28 | $1.41M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $14.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$19.13M derived: sum of 2 quarters · filed 2017-02-28 | -$3.81M derived: sum of 3 quarters · filed 2017-02-28 | -$21.41M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | -$33.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$18.52M derived: sum of 2 quarters · filed 2015-11-06 | -$36.11M 10-Q · filed 2015-11-06 | -$5.61M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $15.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$2.27M 10-Q · filed 2015-08-06 | $28.22M derived: sum of 3 quarters · filed 2016-02-29 | $3.94M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$17.59M 10-Q · filed 2015-05-08 | $12.90M derived: sum of 2 quarters · filed 2016-02-29 | -$11.37M derived: sum of 3 quarters · filed 2016-02-29 | -$19.97M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $30.49M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $6.22M derived: sum of 2 quarters · filed 2016-02-29 | -$2.38M derived: sum of 3 quarters · filed 2016-02-29 | -$35.46M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | -$24.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$32.87M derived: sum of 2 quarters · filed 2014-11-10 | -$65.95M 10-Q · filed 2014-11-10 | $12.95M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-06-30 | -$8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$41.67M 10-Q · filed 2014-08-08 | $37.22M derived: sum of 3 quarters · filed 2015-03-09 | $7.55M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-03-31 | -$33.08M 10-Q · filed 2014-05-12 | $45.82M derived: sum of 2 quarters · filed 2015-03-09 | $16.15M derived: sum of 3 quarters · filed 2015-03-09 | $19.31M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2012-12-31 | $78.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $49.23M derived: sum of 2 quarters · filed 2015-03-09 | $52.39M derived: sum of 3 quarters · filed 2015-03-09 | $21.89M 10-K · filed 2015-03-09 | ||||
| 2012-09-30 | -$29.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$26.50M derived: sum of 2 quarters · filed 2013-11-08 | -$57.01M 10-Q · filed 2013-11-08 | -$31.84M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-06-30 | $3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$27.34M 10-Q · filed 2013-08-06 | -$2.17M derived: sum of 3 quarters · filed 2014-03-10 | -$402.00K derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-03-31 | -$30.50M 10-Q · filed 2013-05-03 | -$5.33M derived: sum of 2 quarters · filed 2014-03-10 | -$3.56M derived: sum of 3 quarters · filed 2014-03-10 | $31.72M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2011-12-31 | $25.17M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $26.94M derived: sum of 2 quarters · filed 2014-03-10 | $62.22M derived: sum of 3 quarters · filed 2014-03-10 | $34.87M 10-K · filed 2014-03-10 | ||||
| 2011-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $37.05M derived: sum of 2 quarters · filed 2012-11-01 | $9.71M 10-Q · filed 2012-11-01 | -$9.67M 10-Q · filed 2011-11-04 | -$56.32M derived: sum of 4 quarters · filed 2013-03-08 | |||
| 2011-06-30 | $35.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $7.94M 10-Q · filed 2012-08-03 | -$7.94M 10-Q · filed 2011-08-05 | -$58.09M derived: sum of 3 quarters · filed 2013-03-08 | -$20.26M derived: sum of 4 quarters · filed 2013-03-08 | |||
| 2011-03-31 | -$27.35M 10-Q · filed 2012-05-04 | -$93.38M derived: sum of 2 quarters · filed 2013-03-08 | -$55.55M derived: sum of 3 quarters · filed 2013-03-08 | |||||
| 2010-12-31 | -$66.03M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | -$28.20M derived: sum of 2 quarters · filed 2013-03-08 | -$19.09M 10-K · filed 2013-03-08 | |||||
| 2010-09-30 | $37.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $46.94M 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | $9.11M 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | $30.02M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |